The American University of Beirut (AUB) recently announced Fadlo R. Khuri, MD, as the 16th President of the University. Dr. Khuri is presently Professor and Chairman of the Department of Hematology and Medical Oncology, Emory University School of Medicine, and holds the Roberto C. Goizueta Distinguished Chair for Cancer Research. He also serves as Deputy Director for the Winship Cancer Institute of Emory University. Dr. Khuri was recently appointed Executive Associate Dean for Research of the Emory University School of Medicine.
An accomplished molecular oncologist and translational thought leader, Dr. Khuri’s clinical expertise and research are focused on the development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with lung and aerodigestive cancers.
Dr. Khuri’s has led the recruitment of over 90 faculty members, including 60 clinical investigators, to Emory University, helping oversee an increase in adult cancer patients placed on trial annually from 143 in 2002 to over 650 in 2014, and paving the way for National Cancer Institute (NCI) Comprehensive Cancer Center designation for Winship. Along with Haian Fu, PhD, Khuri founded Winship’s Cancer Drug Discovery, Development, and Delivery Program.
His published work has been cited over 15,000 times. He serves as Editor-in-Chief of Cancer, and has served on more than a dozen prior editorial boards of major journals. Dr. Khuri has also served as a permanent member of multiple peer review committees for ASCO, the American Cancer Society, and the National Cancer Institute. He is an active member of the American Association for Cancer Research, the International Association for the Study of Lung Cancer, and the American Society for Clinical Investigation, as well as ASCO.
Dr. Khuri earned his medical degree from Columbia University’s College of Physicians and Surgeons. He completed his residency in internal medicine at the Boston City Hospital, and his fellowship in hematology and medical oncology at the Tufts-New England Medical Center. He was on faculty at The University of Texas MD Anderson Cancer Center from 1995–2002 prior to joining Emory University and Winship Cancer Institute in 2003.
Dr. Khuri said, regarding his new position, “It is a genuine honor and a privilege to have been selected to lead AUB into its 150th year. I will engage the AUB community…fully aware of my responsibility to help steward the mission of this great University and its community toward ever more meaningful accomplishment.” ■